Bioprocessing Monitoring Global Market Report 2026

Bioprocess monitoring is the ongoing measurement and evaluation of essential biological, chemical, and physical parameters throughout a bioprocess. It helps maintain optimal operating conditions by ensuring process stability, consistency, and control across the biological production cycle. It enables the early identification of process deviations to facilitate timely adjustments and enhance overall process reliability.

The primary process types of bioprocessing monitoring include upstream bioprocess monitoring and downstream bioprocess monitoring. Upstream bioprocess monitoring refers to the observation of biological processes during cell culture and fermentation stages to maintain optimal production conditions. These systems monitor parameters such as pH, oxygen, temperature, conductivity, turbidity, glucose, lactate, and amino acids and use sensor types including optical, electrochemical, thermal, acoustic, electromagnetic, and biosensors. They are deployed through online and offline monitoring methods and are used by several end users such as biopharmaceutical companies, food and beverage companies, research institutes, and environmental monitoring agencies.

Tariffs are influencing the bioprocess monitoring market by increasing the cost of imported analytical instruments, high-precision sensors, and advanced bioreactor monitoring systems used across upstream and downstream operations. This is disrupting supply chains for biologics and fermentation-based production, particularly in Asia-Pacific and Europe, where dependence on imported components is high, leading to delayed project timelines and higher operational costs. Sensor-based monitoring systems and downstream purification monitoring segments are most affected due to their reliance on globally sourced semiconductor and optical components. However, tariffs are also driving localization of manufacturing, strengthening regional supplier ecosystems, and accelerating domestic innovation in bioprocess instrumentation.

The bioprocessing monitoring market size has grown rapidly in recent years. It will grow from $11.55 billion in 2025 to $12.75 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rise in biologics manufacturing demand driving need for process control, increasing regulatory emphasis on gmp compliant production monitoring, expansion of industrial fermentation in pharmaceuticals and food sectors, growing adoption of automated bioreactors in research labs, need for improved batch consistency and yield optimization in traditional bioprocessing.

The bioprocessing monitoring market size is expected to see strong growth in the next few years. It will grow to $18.63 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for personalized biologics and advanced therapeutics production, expansion of cell and gene therapy manufacturing pipelines, rising focus on continuous bioprocessing and real time quality assurance, growing investments in sustainable and efficient biomanufacturing systems, increasing integration of advanced sensor fusion for predictive process control. Major trends in the forecast period include real time bioreactor parameter tracking for improved yield consistency, adoption of advanced process analytical technology (pat) for inline quality assurance in bioprocessing, increasing use of single use sensor based monitoring systems in flexible manufacturing setups, expansion of aseptic monitoring techniques to enhance contamination control in biologics production, growing integration of high resolution spectroscopy based monitoring for enhanced metabolite and nutrient tracking.

The increasing adoption of personalized medicine is expected to propel the growth of the bioprocess monitoring market going forward. Personalized medicine refers to a medical approach that uses individual genetic and personal data to tailor treatment and improve patient outcomes. The increasing adoption of personalized medicine is driven by advancements in genomic sequencing, which enable faster and more affordable analysis of individual genetic profiles for targeted and more effective treatments. Bioprocess monitoring supports personalized medicine by enabling precise control and real-time monitoring of biological production processes, ensuring that patient-specific therapies such as biologics and cell-based treatments are consistently safe, effective, and tailored to individual needs. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, compared to six in 2022. The personalized treatments approved in 2023 also included seven cancer drugs and three therapies for other diseases and conditions. Therefore, the increasing adoption of personalized medicine is driving the growth of the bioprocess monitoring market.

Leading companies operating in the bioprocess monitoring market are focusing on developing innovative solutions, such as cloud-based bioprocess analytics platforms, to enable real-time process monitoring, centralized data integration, and predictive optimization of biomanufacturing operations. A cloud-based bioprocess analytics platform is a cloud-hosted system that collects and analyzes bioprocess data in real time to improve monitoring, control, and efficiency in biomanufacturing. For example, in July 2024, Eppendorf AG, a Germany-based life science company, launched BioNsight Cloud, a cloud-based digital platform designed to collect, integrate, and analyze bioprocess data in real time from laboratory and biomanufacturing systems. It enables real-time remote process monitoring, multi-user collaboration, and seamless integration with DataHowLab for advanced, AI-driven analytics to accelerate process understanding and optimization.

In March 2025, Repligen Corporation, a US-based life sciences company, acquired the Bioprocessing Analytics Portfolio from 908 Devices Inc. for an undisclosed amount. Through this acquisition, Repligen aimed to strengthen its bioprocessing analytics portfolio by expanding its process analytical technology capabilities for real-time monitoring and optimization of biologics manufacturing. 908 Devices Inc. is a US-based technology company that provides bioprocess monitoring solutions and develops process analytical technology (PAT) solutions.

Major companies operating in the bioprocessing monitoring market are Thermo Fisher Scientific Inc.; Danaher Corporation; Honeywell International Inc.; Emerson Electric Co.; Merck KGaA; Sartorius AG; Agilent Technologies Inc.; Yokogawa Electric Corp.; Waters Corporation; Shimadzu Corporation; Bruker Corporation; Bio-Rad Laboratories Inc.; Endress+Hauser Group Services AG; Repligen Corporation; Eppendorf SE; Nova Biomedical Corporation; Aber Instruments Ltd.; ArgusEye; Adson Biotech; Holloid; Infera; LatchBio

North America was the largest region in the bioprocessing monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioprocessing monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioprocessing monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioprocess monitoring market consists of revenues earned by entities by providing services such as data acquisition and process data logging, contamination detection and control monitoring, and bioreactor performance monitoring and optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioprocess monitoring market also includes sales of biomass sensors, carbon dioxide (CO2) sensors, and flow rate sensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The bioprocessing monitoring market research report is one of a series of new reports from The Business Research Company that provides bioprocessing monitoring market statistics, including bioprocessing monitoring industry global market size, regional shares, competitors with a bioprocessing monitoring market share, detailed bioprocessing monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocessing monitoring industry. This bioprocessing monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bioprocessing Monitoring Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses bioprocessing monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioprocessing monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioprocessing monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Process Type: Upstream Bioprocess Monitoring; Downstream Bioprocess Monitoring
• 2) By Monitoring Parameter: pH; Oxygen; Temperature; Conductivity; Turbidity; Glucose; Lactate; Amino Acids
• 3) By Sensor Type: Optical; Electrochemical; Thermal; Acoustic; Electromagnetic; Biosensors
• 4) By Monitoring Method: Online; Offline
• 5) By End User: Biopharmaceutical Companies; Food And Beverage Companies; Research Institutes; Environmental Monitoring Agencies
• Subsegments:
• 1) By Upstream Bioprocess Monitoring: Cell Culture Monitoring; Fermentation Monitoring; Media Preparation Monitoring; Inoculum Development Monitoring; Bioreactor Monitoring; Process Parameter Monitoring; Microbial Growth Monitoring; Nutrient And Metabolite Monitoring; Gas Analysis Monitoring; Sterility Monitoring
• 2) By Downstream Bioprocess Monitoring: Filtration Monitoring; Centrifugation Monitoring; Chromatography Monitoring; Harvest Monitoring; Purification Monitoring; Buffer Preparation Monitoring; Concentration And Diafiltration Monitoring; Viral Clearance Monitoring; Fill-Finish Monitoring; Quality Control Monitoring
• Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Honeywell International Inc.; Emerson Electric Co.; Merck KGaA; Sartorius AG; Agilent Technologies Inc.; Yokogawa Electric Corp.; Waters Corporation; Shimadzu Corporation; Bruker Corporation; Bio-Rad Laboratories Inc.; Endress+Hauser Group Services AG; Repligen Corporation; Eppendorf SE; Nova Biomedical Corporation; Aber Instruments Ltd.; ArgusEye; Adson Biotech; Holloid; Infera; LatchBio
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.